Taurochenodeoxycholate-7-sulfate
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | |||
| - | |||
<table align='right' border=1> | <table align='right' border=1> | ||
<tr><td> | <tr><td> | ||
| Line 12: | Line 10: | ||
</td></tr></table> | </td></tr></table> | ||
==Description== | ==Description== | ||
| + | [http://172.141.127.22/raghava/hmrbase/test_extract.php?db=arun&table=nphormonet&id=1204&show=SHOW-3D Show 3-D Structure] | ||
| + | |||
affects bile flow and biliary lipids; RN refers to di-Na salt; structure given in first source | affects bile flow and biliary lipids; RN refers to di-Na salt; structure given in first source | ||
==General Properties== | ==General Properties== | ||
| Line 55: | Line 55: | ||
| - | [[ | + | [[Category:Hormones]] |
| + | [[Category:HMRbase]] | ||
Current revision
|
|
Contents |
[edit] Description
affects bile flow and biliary lipids; RN refers to di-Na salt; structure given in first source
[edit] General Properties
*Molecular Weight
623.73
*Molecular Formula
C26H45NO9S2
*IUPAC NAME
disodium2-[[(4R)-4-[(3R,5S,7R,10S,13R,17R)-3-hydroxy-10,13-dimethyl-7-sulfonatooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate
*Canonical Smiles
CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)OS(=O)(=O)[O-])C.[Na+].[Na+]
*Isomeric Smiles
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CCC2[C@@]1(CCC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)OS(=O)(=O)[O-])C.[Na+].[Na+]
[edit] PhysioChemical Properties
*Melting Point
*LogP
*Water Solubility
